Cytomics Systems Completes A € 10 Million Round Of Financing.
Second round to enable the Company, focused on the discovery and development of small molecules controlling protein turnover, to advance its therapeutic pipeline in the field of fungal infections and oncology. Two new investors, Edmond de Rothschild Investment Partners and Truffle Venture, join existing investor Société Générale Asset Management AI (SGAM AI)
(Read the full version below in pdf format)
|